Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

SFD


Fundamental

Company: Smithfield Foods, Inc
Sector: Consumer Defensive
Industry: Packaged Foods
Country: USA
Exchange: NASD
Index: -
P/E: -
EPS (ttm): -
Insider Own: 93.67%
Shs Outstand: 393.11M
Perf Week: -0.46%
Market Cap: 9.42B
Forward P/E: 10.32
EPS next Y: 2.32
Insider Trans: -3.22%
Shs Float: 24.88M
Perf Month: 1.72%
Enterprise Value: 11.07B
PEG: -
EPS next Q: 0.55
Inst Own: 6.57%
Short Float: 5.55%
Perf Quarter: 20.40%
Income: -
P/S: -
EPS this Y: 23.39%
Inst Trans: 25.97%
Short Ratio: 2.32
Perf Half Y: -
Sales: -
P/B: 1.51
EPS next Y Percentage: 0.09%
ROA: -
Short Interest: 1.38M
Perf YTD: 21.32%
Book/sh: 15.84
P/C: 10.15
EPS next 5Y: 8.03%
ROE: -
52W High: 24.68 -2.92%
Perf Year: -
Cash/sh: 2.36
P/FCF: -
EPS past 3/5Y: 26.39% -
ROIC: -
52W Low: 18.43 30.01%
Perf 3Y: -
Dividend Est.: 0.92 (3.84%)
EV/EBITDA: -
Sales past 3/5Y: -2.35% -
Gross Margin: -
Volatility W: 2.21%
Volatility M: 2.02%
Perf 5Y: -
Dividend TTM: 0.50 (2.09%)
EV/Sales: -
EPS Y/Y TTM: -
Oper. Margin: -
ATR (14): 0.49
Perf 10Y: -
Dividend Ex-Date: May 15, 2025
Quick Ratio: 1.40
Sales Y/Y TTM: -
Profit Margin: -
RSI (14): 55.50
Recom: 1.43
Dividend Gr. 3/5Y: - -
Current Ratio: 3.11
EPS Q/Q: -
SMA20: 1.02%
Beta: -
Target Price: 28.38
Payout: -
Debt/Eq: 0.38
Sales Q/Q: -
SMA50: 2.77%
Rel Volume: 1.22
Prev Close: 23.60
Employees: 34000
LT Debt/Eq: 0.37
Earnings: Apr 29 BMO
SMA200: 10.63%
Avg Volume: 594.68K
Price: 23.96
IPO: Jan 28, 2025
Option/Short: Yes / Yes
EPS/Sales Surpr.: 21.04% 3.83%
Trades:
Volume: 723,109
Change: 1.53%

Technical:


Latest News:

USFDA approves Pfizer Adcetris combination regimen for Relapsed/Refractory Diffuse ... very bullish
PFE

Summary: Pfizer Inc. receives FDA approval for the supplemental BLA for ADCETRIS in combination therapy for the treatment of relapsed or refractory large B-cell lymphoma, showing significant improvement in overall survival based on Phase 3 study. The therapy provides a new option for patients who have failed two prior lines of therapy.

Full article
2025-02-13T10:18:31Z
EEOC brings lawsuit against Smithfield Foods | MEAT+POULTRY somewhat bearish
SFD

Summary: The US EEOC filed a lawsuit against Smithfield Foods Inc., alleging age discrimination against a senior sales employee who was fired at the age of 59. Smithfield claimed termination was part of a reduction-in-force, but most terminated employees were 55 or older. The case will be heard in the US District Court for the Northern District of Georgia.

Full article
2024-05-21T13:25:52Z
Envestnet, Salesforce join forces on advisor platform - Financial Planning somewhat bullish
ENV SFDC

Summary: Envestnet and Salesforce have partnered to offer advisors a more streamlined platform on the cloud for financial planning, aiming to help advisors operate across multiple systems and applications on one platform for better portfolio monitoring and client engagement.

Full article
2024-05-13T17:38:18Z
More casualties in US trucking sector expected after Q1 slump in volume and spend - The Loadstar somewhat bearish
USFD

Summary: The US trucking market continues to struggle as shown by US Bank’s Freight Payment Index for the first quarter, which revealed declines in shipment count and freight spending. Winter storms, decreased demand after peak season, and other factors contributed to the challenges faced by the trucking sector. Despite some economic indicators pointing to improvement, analysts predict ongoing difficulties due to excess capacity in the market.

Full article
2024-05-01T11:22:56Z
USFDA approves Biktarvy label update with data for pregnant adults with HIV: Gilead Sciences neutral
GILD

Summary: Gilead Sciences, Inc. receives FDA approval for updated label on Biktarvy for treating pregnant people with HIV-1, reinforcing safety and efficacy profile.

Full article
2024-04-28T06:08:22Z
Medtronic gets USFDA approval for Inceptiv closed-loop spinal cord stimulator for chronic pain very bullish
MDT

Summary: Medtronic is launching the Inceptiv SCS, a new spinal cord stimulation system that offers real-time adjustments to stimulation based on the body's response. It provides full-body MRI access without restrictions and is designed for patient comfort, offering multiple types of waveforms and a mobile application for therapy guidance. The system has already been approved for sale in Europe and Japan, and will soon launch in the U.S.

Full article
2024-04-27T11:29:18Z
USFDA nod to Pfizer Beqvez for adults with Hemophilia B - Medical Dialogues neutral
PFE

Summary: Pfizer Inc. has announced FDA approval for BEQVEZ for the treatment of adults with moderate to severe hemophilia B, offering a one-time gene therapy as an alternative to regular FIX infusions.

Full article
2024-04-27T06:39:40Z